The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2014060621
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Fibroblast Growth Factor 23 and Inflammation in CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD

American Journal of Kidney Diseases
Nephrology
2013English

Fibroblast Growth Factor-23 May Serve as a Novel Biomarker for Renal Osteodystrophy Progression

International Journal of Molecular Medicine
MedicineGenetics
2018English

Fibroblast Growth Factor 23 and the Last Mile

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2020English

Inflammation Regulates Fibroblast Growth Factor 23 Production

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Multiple Faces of Fibroblast Growth Factor-23

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Fibroblast Growth Factor 23: Friend or Foe in Uremia?

Journal of Clinical Investigation
Medicine
2012English

Serum Fibroblast Growth Factor-23 and Incident Hypertension

Journal of Hypertension
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2016English

Regulation of Fibroblast Growth Factor 23 ( FGF 23) in Health and Disease

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy